advertisement
Nakazawa T 21
Showing records 1 to 21 | Display all abstracts from Nakazawa T99242 A Plant-Derived Antioxidant Supplement Prevents the Loss of Retinal Ganglion Cells in the Retinas of NMDA-Injured Mice
Maekawa S
Clinical Ophthalmology 2022; 16: 823-832
98619 Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan
Nakazawa T
Advances in Therapy 2022; 39: 1359-1374
99345 The Enantiomer of Allopregnanolone Prevents Pressure-Mediated Retinal Degeneration Via Autophagy
Ishikawa M
Frontiers in pharmacology 2022; 13: 855779
99242 A Plant-Derived Antioxidant Supplement Prevents the Loss of Retinal Ganglion Cells in the Retinas of NMDA-Injured Mice
Sato K
Clinical Ophthalmology 2022; 16: 823-832
98619 Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan
Takahashi K
Advances in Therapy 2022; 39: 1359-1374
99345 The Enantiomer of Allopregnanolone Prevents Pressure-Mediated Retinal Degeneration Via Autophagy
Nakazawa T
Frontiers in pharmacology 2022; 13: 855779
99242 A Plant-Derived Antioxidant Supplement Prevents the Loss of Retinal Ganglion Cells in the Retinas of NMDA-Injured Mice
Kokubun T
Clinical Ophthalmology 2022; 16: 823-832
98619 Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan
Kuwayama Y
Advances in Therapy 2022; 39: 1359-1374
99345 The Enantiomer of Allopregnanolone Prevents Pressure-Mediated Retinal Degeneration Via Autophagy
Kunikata H
Frontiers in pharmacology 2022; 13: 855779
98619 Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan
Nomura A
Advances in Therapy 2022; 39: 1359-1374
99345 The Enantiomer of Allopregnanolone Prevents Pressure-Mediated Retinal Degeneration Via Autophagy
Sato K
Frontiers in pharmacology 2022; 13: 855779
99242 A Plant-Derived Antioxidant Supplement Prevents the Loss of Retinal Ganglion Cells in the Retinas of NMDA-Injured Mice
Himori N; Yabana T
Clinical Ophthalmology 2022; 16: 823-832
99345 The Enantiomer of Allopregnanolone Prevents Pressure-Mediated Retinal Degeneration Via Autophagy
Yoshitomi T
Frontiers in pharmacology 2022; 13: 855779
98619 Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan
Shimada F
Advances in Therapy 2022; 39: 1359-1374
99242 A Plant-Derived Antioxidant Supplement Prevents the Loss of Retinal Ganglion Cells in the Retinas of NMDA-Injured Mice
Ohno-Oishi M
Clinical Ophthalmology 2022; 16: 823-832
99345 The Enantiomer of Allopregnanolone Prevents Pressure-Mediated Retinal Degeneration Via Autophagy
Krishnan K
Frontiers in pharmacology 2022; 13: 855779
99242 A Plant-Derived Antioxidant Supplement Prevents the Loss of Retinal Ganglion Cells in the Retinas of NMDA-Injured Mice
Shi G
Clinical Ophthalmology 2022; 16: 823-832
99345 The Enantiomer of Allopregnanolone Prevents Pressure-Mediated Retinal Degeneration Via Autophagy
Covey DF; Zorumski CF
Frontiers in pharmacology 2022; 13: 855779
99242 A Plant-Derived Antioxidant Supplement Prevents the Loss of Retinal Ganglion Cells in the Retinas of NMDA-Injured Mice
Omodaka K
Clinical Ophthalmology 2022; 16: 823-832
99345 The Enantiomer of Allopregnanolone Prevents Pressure-Mediated Retinal Degeneration Via Autophagy
Izumi Y
Frontiers in pharmacology 2022; 13: 855779
99242 A Plant-Derived Antioxidant Supplement Prevents the Loss of Retinal Ganglion Cells in the Retinas of NMDA-Injured Mice
Nakazawa T
Clinical Ophthalmology 2022; 16: 823-832
